Webinar: Alpha-1 Antitrypsin Deficiency in COPD
Understanding the implications for your patients
Webinar given on June 7th 2019 by Dr. Miriam Barrecheguren
Objectives
-
To understand what AATD is and what the consequences are for an individual with COPD
-
To identify the target clientele who should be tested for AATD
-
To understand the diagnostic process
-
To understand the treatment, including augmentation therapy, as well as long-term adherence and lifestyle improvements to live better with AATD
About Our Speaker
Miriam Barrecheguren, MD, PhD
Dr. Miriam Barrecheguren is a pneumologist who currently works at Vall
d’Hebron University Hospital in Barcelona. Her main areas of interest include COPD,
AATD and mechanical ventilation. After earning her Ph.D. in 2016, on the diagnosis
and management of COPD and AATD in Primary Care, she fulfilled a research fellow
at McGill University and was then granted a Rio Hortega grant to continue her work
in Barcelona. She is the Early Career representative for the European Respiratory
Society (ERS) in the European Alpha-1 research collaboration (EARCO).
